{"gene":"ABCC9","run_date":"2026-04-28T17:12:36","timeline":{"discoveries":[{"year":1996,"finding":"ABCC9 encodes SUR2A and SUR2B, alternatively spliced isoforms of the sulfonylurea receptor that form the regulatory subunit of cardiac, skeletal muscle, and vascular KATP channels by partnering with the inwardly rectifying K+ channel subunit KIR6.2; SUR2A is expressed exclusively in heart while SUR2B is ubiquitous.","method":"cDNA cloning, Northern blotting, RT-PCR, in situ hybridization, FISH chromosomal localization","journal":"Diabetes","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal methods in foundational cloning paper, highly cited","pmids":["8826984"],"is_preprint":false},{"year":1998,"finding":"The C-terminal 42 amino acid residues that differ between SUR2A and SUR2B determine subtype-selective pharmacological activation of KATP channels; nicorandil preferentially activates SUR2B/Kir6.2 channels (>100-fold lower EC50) over SUR2A/Kir6.2 channels, implicating the C-terminal tail in drug selectivity.","method":"Heterologous expression in HEK293T cells, patch-clamp electrophysiology (cell-attached and whole-cell configurations)","journal":"British journal of pharmacology","confidence":"High","confidence_rationale":"Tier 1 — reconstituted channel in heterologous system with quantitative pharmacology, replicated across SUR2 subtypes","pmids":["9692785"],"is_preprint":false},{"year":2001,"finding":"Disruption of SUR2-containing KATP channels in skeletal muscle enhances insulin-stimulated glucose uptake, demonstrating that SUR2-dependent membrane excitability is a component of the insulin-stimulated glucose uptake mechanism.","method":"Gene-targeted Sur2 knockout mice, glucose tolerance tests, hyperinsulinemic euglycemic clamp, in vitro insulin-stimulated glucose transport assay in isolated muscle","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 — clean KO with multiple defined physiological readouts, in vivo and in vitro","pmids":["11562480"],"is_preprint":false},{"year":2002,"finding":"Sur2-containing KATP channels in vascular smooth muscle are critical regulators of episodic vasomotor activity; Sur2 null mice develop elevated resting blood pressure, sudden death, and episodic coronary artery vasospasm that is reversible by calcium channel antagonist treatment.","method":"Gene-targeted Sur2 knockout mice, in vivo hemodynamic monitoring, coronary angiography, pharmacological rescue with nifedipine","journal":"The Journal of clinical investigation","confidence":"High","confidence_rationale":"Tier 2 — clean KO with defined vascular phenotype, in vivo monitoring, pharmacological validation","pmids":["12122112"],"is_preprint":false},{"year":2002,"finding":"The C-terminal 42 amino acid residues of SUR2 subtypes mediate intramolecular interaction with the second nucleotide-binding domain (NBD2), specifically a 7-residue segment that electrostatically interacts with Arg1344 at the Walker-A loop of NBD2, determining ADP-induced differential activation of KATP channels in SUR2A vs SUR2B.","method":"Chimeric SUR2A/SUR2B constructs expressed with Kir6.2, patch-clamp electrophysiology, 3D structural modeling based on HisP crystal structure","journal":"Circulation research","confidence":"Medium","confidence_rationale":"Tier 2 — chimeric mutant analysis with electrophysiology plus structural modeling; single lab","pmids":["11909819"],"is_preprint":false},{"year":2004,"finding":"Two ABCC9 missense and frameshift mutations identified in dilated cardiomyopathy patients map to conserved domains adjacent to the catalytic ATPase pocket within SUR2A, causing aberrant redistribution of conformations in the intrinsic ATP hydrolytic cycle that translates into abnormal KATP channel phenotypes with compromised metabolic signal decoding.","method":"Genomic DNA scanning, functional expression of mutant SUR2A, electrophysiology (inside-out patch-clamp), ATPase activity assays","journal":"Nature genetics","confidence":"High","confidence_rationale":"Tier 1 — in vitro enzymatic and electrophysiology assays with disease mutations, multiple orthogonal methods","pmids":["15034580"],"is_preprint":false},{"year":2007,"finding":"Conventional sarcolemmal cardiomyocyte KATP channels containing full-length SUR2 are not required for mediating cardioprotection against acute ischemia-reperfusion injury; SUR2 null mice show reduced infarct size, and nifedipine treatment to block baseline vasospasm reveals that the protection is partly vasospasm-dependent.","method":"SUR2 null mice, Langendorff-perfused heart ischemia model, infarct size measurement, nifedipine pharmacological dissection","journal":"Journal of molecular and cellular cardiology","confidence":"Medium","confidence_rationale":"Tier 2 — clean KO with defined cardiac phenotype; single lab but multiple readouts","pmids":["17765261"],"is_preprint":false},{"year":2008,"finding":"SUR2A contains asymmetric NBD1 and NBD2 domains; heterodomain NBD1/NBD2 interaction produces conformational rearrangements and enhances intrinsic ATPase activity. Mutation of the predicted catalytic base residue D834E in NBD1 alters NBD1 ATPase activity and disrupts potentiation of catalytic behavior, establishing NBD1/NBD2 assembly as the molecular basis for optimal SUR2A catalytic activity.","method":"Purified recombinant NBD1/NBD2 domains, dynamic light scattering, circular dichroism, atomic force microscopy, transmission electron microscopy, ATPase activity assays, site-directed mutagenesis","journal":"Journal of proteome research","confidence":"High","confidence_rationale":"Tier 1 — reconstitution with purified proteins, multiple structural methods, mutagenesis validation","pmids":["18311911"],"is_preprint":false},{"year":2010,"finding":"SUR2 subunits are essential for trafficking KATP channels to an intracellular endosomal/lysosomal compartment; SUR2-containing channels dynamically cycle between endosomal and plasmalemmal compartments, and ischemia shifts this balance toward the sarcolemmal fraction, increasing surface KATP channel density without changing mRNA levels.","method":"Immunofluorescence microscopy, surface HA-tag labeling, subcellular fractionation of rat hearts, patch-clamp recording from ischemic ventricular myocytes","journal":"American journal of physiology. Heart and circulatory physiology","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal localization and functional methods; in vitro and ex vivo validation","pmids":["20971764"],"is_preprint":false},{"year":2010,"finding":"SUR2 mutant mice have an altered mitochondrial phenotype including less polarized mitochondrial membrane potential, increased Ca2+ tolerance, enhanced ROS generation, and greater K+ influx compared to wild-type, consistent with SUR2 participation in mitochondrial KATP channel function and providing a basis for ischemic cardioprotection.","method":"Fluorescence-based assays of mitochondrial membrane potential, Ca2+ loading, ROS; light scattering volumetric assays; isolated mitochondria and intact myocyte experiments","journal":"American journal of physiology. Heart and circulatory physiology","confidence":"Medium","confidence_rationale":"Tier 2 — multiple mitochondrial assays in SUR2 mutant model; single lab","pmids":["20935152"],"is_preprint":false},{"year":2011,"finding":"SUR2B is the sole SUR isoform expressed in murine cerebral artery smooth muscle cells, and SUR2-containing KATP channels mediate vasodilation induced by oxygen/glucose deprivation (OGD) and metabolic inhibition but not by hypoxia alone; loss of SUR2 impairs postischemic loss of myogenic tone.","method":"SUR2 null mice, pressurized cerebral artery myography, pinacidil pharmacology, hypoxia/OGD/metabolic inhibitor protocols, RT-PCR isoform identification","journal":"American journal of physiology. Heart and circulatory physiology","confidence":"High","confidence_rationale":"Tier 2 — genetic model with multiple pharmacological and physiological readouts, isoform identification","pmids":["21784985"],"is_preprint":false},{"year":2012,"finding":"Dominant missense mutations in ABCC9 cause Cantú syndrome by reducing ATP-mediated inhibition of KATP channels, resulting in gain-of-function channel opening; all mutations alter amino acids in or near the transmembrane domains of SUR2.","method":"Exome sequencing of affected families, Sanger sequencing, electrophysiological measurements of mutant channel ATP sensitivity","journal":"Nature genetics","confidence":"High","confidence_rationale":"Tier 2 — direct electrophysiology of mutant channels; replicated across 16 individuals from multiple labs","pmids":["22610116"],"is_preprint":false},{"year":2012,"finding":"Cantú syndrome ABCC9 mutations are heterozygous missense variants with a hotspot at Arg1154 within the second type 1 transmembrane region, consistent with an activating (gain-of-function) mechanism for KATP channels.","method":"Exome sequencing of proband-parent trios and unrelated cases, Sanger sequencing","journal":"American journal of human genetics","confidence":"Medium","confidence_rationale":"Tier 3 — genetic identification with mutation clustering at functional domain; no direct electrophysiology in this paper","pmids":["22608503"],"is_preprint":false},{"year":2012,"finding":"CpG methylation of the ABCC9/SUR2 promoter region regulates SUR2 expression in HL-1 cardiomyocytes; 57.6% of CpGs in the SUR2 promoter are methylated versus 0.14% for SUR1, and demethylation with 5-aza-2'-deoxycytidine increases SUR2 mRNA expression.","method":"Bisulfite sequencing of genomic DNA, 5-aza-dC treatment, quantitative RT-PCR","journal":"PloS one","confidence":"Medium","confidence_rationale":"Tier 2 — bisulfite sequencing plus pharmacological demethylation with gene expression readout; single lab","pmids":["22844491"],"is_preprint":false},{"year":2013,"finding":"The ABCC9 V734I mutation (in NBD1) selectively reduces MgATP inhibition and MgNDP activation of Kir6.2/SUR2B vascular channels but not Kir6.2/SUR2A cardiac or Kir6.1/SUR2B channels, linking impaired nucleotide sensing in vascular KATP channels to susceptibility to coronary vasospasm and myocardial infarction.","method":"Patch-clamp electrophysiology of recombinant channels in heterologous expression system, inside-out and whole-cell configurations","journal":"International journal of cardiology","confidence":"High","confidence_rationale":"Tier 1 — in vitro electrophysiology with isoform-selective functional dissection; directly links mutation to channel mechanism","pmids":["23739550"],"is_preprint":false},{"year":2013,"finding":"A SUR2A splice variant (SUR2A-55) lacking NBD1 and two transmembrane domains can co-assemble with Kir6.1 and Kir6.2 to form functional KATP channels with 70-fold reduced ATP sensitivity and markedly reduced drug sensitivity, suggesting it as a candidate mitoKATP regulatory subunit.","method":"Heterologous expression in COS cells, patch-clamp electrophysiology, pharmacological profiling with pinacidil/diazoxide/glibenclamide","journal":"Channels (Austin, Tex.)","confidence":"Medium","confidence_rationale":"Tier 1 — reconstituted channel with in vitro electrophysiology; single lab, candidate assignment remains speculative","pmids":["24037327"],"is_preprint":false},{"year":2014,"finding":"Abcc9 is required for the neonatal heart's transition from glycolytic to oxidative metabolism; deletion of exon 5 ablates both plasma membrane and mitochondria-associated Abcc9 proteins, causing neonatal cardiomyopathy with reduced fatty acid oxidation, reduced oxygen consumption, and mitochondrial immaturity.","method":"Exon 5 knockout mice, mitochondrial membrane potential assays, fatty acid oxidation assays, oxygen consumption measurements, electron microscopy of cardiac mitochondria, diazoxide KATP agonist testing","journal":"FASEB journal","confidence":"High","confidence_rationale":"Tier 2 — clean KO with multiple orthogonal metabolic and morphological readouts; pharmacological dissection","pmids":["24648545"],"is_preprint":false},{"year":2014,"finding":"ABCC9 gain-of-function mutations cause early repolarization and Brugada syndromes by increasing KATP channel activity; V734I-ABCC9 increases Mg-ATP IC50 5-fold and S1402C-ABCC9 shifts ATP IC50, both producing gain-of-function IK-ATP.","method":"Direct sequencing of susceptibility genes, whole-cell and inside-out patch-clamp in TSA201 cells expressing mutant SUR2A with Kir6.2","journal":"International journal of cardiology","confidence":"High","confidence_rationale":"Tier 1 — in vitro electrophysiology with mutagenesis; multiple mutations characterized","pmids":["24439875"],"is_preprint":false},{"year":2015,"finding":"Three Cantú syndrome ABCC9 mutations (P432L, A478V, C1043Y) all produce gain-of-function KATP channels but through at least two distinct mechanisms: P429L and A475V enhance MgADP activation with normal ATP sensitivity, while C1039Y reduces sensitivity to both ATP inhibition and glibenclamide block without affecting MgADP activation.","method":"Rubidium efflux assays, inside-out patch-clamp electrophysiology; engineered mutations in rat SUR2A expressed with mouse Kir6.2","journal":"The Journal of general physiology","confidence":"High","confidence_rationale":"Tier 1 — reconstituted channels, two orthogonal assays (86Rb efflux + patch-clamp), mechanistic dissection of multiple mutations","pmids":["26621776"],"is_preprint":false},{"year":2015,"finding":"ABCC9 rs704180 risk allele functions as an expression quantitative trait locus (eQTL) in brain, associated with increased ABCC9 transcript levels and enrichment for a shorter 3' UTR; miR-30c down-regulates SUR2 transcripts with the longer 3' UTR.","method":"3' RACE of human brain cDNA, eQTL analysis across multiple brain expression databases, microRNA transfection experiments","journal":"Journal of neurochemistry","confidence":"Medium","confidence_rationale":"Tier 3 — miRNA transfection with expression readout; eQTL is associative but miRNA effect experimentally tested","pmids":["26115089"],"is_preprint":false},{"year":2019,"finding":"Homozygous loss-of-function splice-site mutation in ABCC9 (c.1320+1 G>A) causing in-frame deletion of exon 8 results in non-functional SUR2-containing KATP channels and produces a syndrome (AIMS) of intellectual disability, myopathy, and cardiac dysfunction; SUR2 loss-of-function causes fatigability and cardiac dysfunction in mice and zebrafish.","method":"Patient exome sequencing, recombinant channel expression with electrophysiology, SUR2 knockout mouse and zebrafish models with functional phenotyping","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 1-2 — recombinant channel assay plus two in vivo model organisms with defined phenotypes","pmids":["31575858"],"is_preprint":false},{"year":2020,"finding":"Kir6.1/SUR2-containing KATP channels underlie smooth muscle KATP throughout the intestine; gain-of-function mutations in Kir6.1/SUR2 (Cantú syndrome knockin mice) reduce intestinal contractility and cause GI dysmotility reversible by glibenclamide, a KATP inhibitor.","method":"Kir6.1/SUR2 knockin mice carrying human CS mutations, intestinal contractility assays, glibenclamide pharmacological rescue, subunit identification by genetic ablation","journal":"JCI insight","confidence":"High","confidence_rationale":"Tier 2 — knockin mouse model with defined smooth muscle phenotype and pharmacological rescue","pmids":["33170808"],"is_preprint":false},{"year":2021,"finding":"SUR2[A478V] gain-of-function knockin mutation reduces MgATP sensitivity of KATP currents in skeletal muscle fibers and causes muscle atrophy with up-regulation of atrogin-1 and MuRF1 mRNA, linking KATP overactivity to skeletal muscle atrophy in Cantú syndrome.","method":"Heterozygous and homozygous SUR2[A478V] knockin mice, patch-clamp of Flexor digitorum brevis fibers, muscle histopathology, qPCR of atrophy markers","journal":"Cells","confidence":"High","confidence_rationale":"Tier 2 — knockin model with patch-clamp, histology, and molecular markers; multiple orthogonal readouts","pmids":["34359961"],"is_preprint":false},{"year":2021,"finding":"SUR2[R1154Q] Cantú syndrome mutation causes near-complete loss of SUR2 protein and KATP channel activity in homozygous ventricular tissue due to aberrant splicing (in-frame deletion of exon 28 in ~90% of transcripts from homozygous tissue), revealing that ABCC9 mutations can act through mRNA mis-splicing rather than purely by altered channel gating.","method":"CRISPR/Cas9 knockin mice, cDNA sequencing, recombinant expression of SUR2A lacking exon 28, patch-clamp electrophysiology, hiPSC-derived cardiomyocyte analysis","journal":"JCI insight","confidence":"High","confidence_rationale":"Tier 1-2 — CRISPR knockin plus recombinant channel expression plus human iPSC; multiple orthogonal methods","pmids":["33529173"],"is_preprint":false},{"year":2022,"finding":"Cryo-EM structures of SUR2A and SUR2B in complex with Mg-nucleotides and KATP openers P1075 or levcromakalim reveal that both vasodilators bind a common site in the transmembrane domain between TMD1 and TMD2 (embraced by TM10, TM11, TM12, TM14, and TM17), and synergize with Mg-nucleotides to stabilize SUR2 in the NBD-dimerized occluded state to activate the channel.","method":"Cryo-EM structure determination of SUR2A and SUR2B with bound ligands","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 1 — cryo-EM structures at high resolution identifying specific drug binding site and conformational mechanism","pmids":["35562524"],"is_preprint":false},{"year":2022,"finding":"KCNJ8/ABCC9-containing KATP channels cell-autonomously regulate brain vascular smooth muscle cell (VSMC) differentiation through modulation of intracellular Ca2+ oscillation via voltage-dependent calcium channels; loss or gain of KATP function suppresses or promotes arterial VSMC differentiation, and Kcnj8 KO mice show deficient vasoconstrictive capacity and impaired neurovascular coupling.","method":"Kcnj8 KO mice, zebrafish genetic models, chemical KATP inhibition/activation, live imaging of Ca2+ oscillations, VSMC differentiation assays in cell culture","journal":"Developmental cell","confidence":"High","confidence_rationale":"Tier 2 — multiple model systems (mouse, zebrafish, cell culture), live Ca2+ imaging, genetic and pharmacological dissection","pmids":["35588738"],"is_preprint":false},{"year":2023,"finding":"Loss of SUR2 in skeletal muscle specifically underlies myopathy in AIMS; ABCC9 loss-of-function results in abnormal generation of unstimulated forces in isolated muscle, and CaV1.1 channel blockade by verapamil causes premature death in AIMS mice, indicating Ca2+ influx through CaV1.1 is not the primary pathological mechanism.","method":"Tissue-selective KATP suppression with premature stop codon mouse models, isolated muscle force measurements, verapamil pharmacological intervention, CaV1.1 non-permeable mutant genetic rescue","journal":"EMBO molecular medicine","confidence":"High","confidence_rationale":"Tier 2 — tissue-selective genetic model, isolated muscle physiology, pharmacological and genetic rescue experiments","pmids":["37154692"],"is_preprint":false},{"year":2024,"finding":"SUR2 undergoes ligand-dependent dynamic conformational changes between an inhibitory inward-facing conformation and an activating occluded conformation; Mg-ADP binding to NBD2 competes with inhibitory Mg-ATP to promote release of a unique inhibitory Regulatory helix (R helix) absent in SUR1, initiating channel activation; the C-terminal 42 residues (C42) allosterically regulate Mg-nucleotide binding kinetics on NBD2.","method":"Structural studies (cryo-EM) with functional validation (referenced as 'recent structural studies')","journal":"BioEssays : news and reviews in molecular, cellular and developmental biology","confidence":"Medium","confidence_rationale":"Tier 1 — based on structural data; this is a review/synthesis paper citing recent cryo-EM work, so primary data in cited structural papers","pmids":["38227376"],"is_preprint":false},{"year":2025,"finding":"SUR2[H60Y] Cantú syndrome mutation causes gain-of-function selectively in Kir6.1-SUR2B channels but not Kir6.2-SUR2B channels; chimeric and mutagenesis analysis identifies the N and C termini of Kir6.1 and specifically valine 334 in Kir6.1 as necessary for this isoform-specific GOF effect.","method":"DiBAC4(3) membrane potential measurements in intact cells expressing Kir6.1/Kir6.2-SUR2 combinations, chimeric channel approach, site-directed mutagenesis of Kir6.1","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — mutagenesis and chimeric constructs with functional assay; mechanistic dissection of isoform specificity","pmids":["41448431"],"is_preprint":false}],"current_model":"ABCC9 encodes SUR2 (SUR2A and SUR2B splice isoforms), the regulatory subunit of ATP-sensitive potassium (KATP) channels that couples cellular metabolic state to membrane excitability: SUR2 assembles with Kir6.x pore-forming subunits into heterooctameric KATP complexes in cardiac, skeletal, and vascular smooth muscle; its asymmetric NBD1/NBD2 domains catalyze ATP hydrolysis and sense Mg-nucleotides (Mg-ATP inhibitory, Mg-ADP activating via a unique R-helix release mechanism), K+ channel opener drugs bind a transmembrane domain site between TMD1 and TMD2 to stabilize the NBD-dimerized occluded activating state, and loss-of-function or gain-of-function mutations cause a spectrum of diseases (dilated cardiomyopathy, Cantú syndrome, AIMS) by respectively preventing or constitutively enabling channel opening, while SUR2 also directs KATP channel trafficking to endosomal compartments and participates in mitochondrial metabolism and neonatal cardiac metabolic maturation."},"narrative":{"teleology":[{"year":1996,"claim":"Identification of ABCC9 as encoding two alternatively spliced sulfonylurea receptor isoforms (SUR2A and SUR2B) that partner with Kir6.2 to form tissue-specific KATP channels established the molecular identity of cardiac, skeletal, and vascular smooth muscle KATP regulatory subunits.","evidence":"cDNA cloning, Northern blotting, RT-PCR, in situ hybridization, and FISH chromosomal localization","pmids":["8826984"],"confidence":"High","gaps":["Stoichiometry of SUR2/Kir6.x assembly not yet defined","Structural basis of SUR2-Kir6.x coupling unknown"]},{"year":1998,"claim":"Demonstrating that the 42 C-terminal residues distinguishing SUR2A from SUR2B determine subtype-selective pharmacological activation (>100-fold difference in nicorandil EC50) established the molecular basis for isoform-specific drug selectivity.","evidence":"Heterologous expression in HEK293T cells with patch-clamp electrophysiology across SUR2 subtypes","pmids":["9692785"],"confidence":"High","gaps":["How C-terminal residues structurally couple to the drug-binding site was unknown","Whether this selectivity extends to all K-channel openers was untested"]},{"year":2002,"claim":"Knockout mouse studies revealed that SUR2-containing KATP channels are essential regulators of vascular tone, insulin-stimulated glucose uptake, and survival: Sur2-null mice exhibit coronary vasospasm, hypertension, sudden death, and enhanced muscle glucose uptake, defining the in vivo physiological roles of these channels.","evidence":"Sur2 knockout mice with hemodynamic monitoring, coronary angiography, nifedipine rescue, hyperinsulinemic clamp, and isolated muscle glucose transport assays","pmids":["12122112","11562480"],"confidence":"High","gaps":["Relative contributions of SUR2A vs SUR2B to each phenotype not dissected","Compensatory mechanisms in global knockout not excluded"]},{"year":2002,"claim":"Chimeric SUR2A/SUR2B analysis showed that the C-terminal 42 residues interact intramolecularly with Arg1344 at the Walker-A loop of NBD2, providing the first structural model for how isoform-specific C-termini differentially regulate ADP-induced channel activation.","evidence":"Chimeric SUR2A/SUR2B constructs with Kir6.2, patch-clamp electrophysiology, homology modeling","pmids":["11909819"],"confidence":"Medium","gaps":["Based on homology modeling rather than direct structural data","Interaction not confirmed by direct binding assays with isolated domains"]},{"year":2004,"claim":"Discovery that ABCC9 mutations in dilated cardiomyopathy patients alter the intrinsic ATPase cycle of SUR2A established the first link between aberrant SUR2 catalytic activity and human cardiac disease, demonstrating that SUR2 functions as a metabolic signal decoder.","evidence":"Genomic DNA scanning of cardiomyopathy patients, functional expression of mutant SUR2A, inside-out patch-clamp, ATPase activity assays","pmids":["15034580"],"confidence":"High","gaps":["Exact structural consequences of mutations on NBD conformation unknown","Whether these mutations also affect trafficking was not tested"]},{"year":2008,"claim":"Reconstitution of purified NBD1 and NBD2 domains demonstrated that SUR2A possesses intrinsically asymmetric NBDs whose heterodimeric assembly is required for optimal ATPase catalytic activity, revealing the enzymatic architecture underlying metabolic sensing.","evidence":"Purified recombinant NBD1/NBD2, ATPase assays, dynamic light scattering, circular dichroism, AFM, TEM, site-directed mutagenesis of catalytic base D834E","pmids":["18311911"],"confidence":"High","gaps":["Full-length SUR2 catalytic cycle not reconstituted","Coupling of NBD ATPase to channel gating not demonstrated biochemically"]},{"year":2010,"claim":"SUR2 was shown to direct KATP channels to intracellular endosomal/lysosomal compartments, with ischemia shifting channel distribution to the sarcolemma; separately, SUR2-null mitochondria showed altered membrane potential, Ca2+ tolerance, and ROS generation, expanding SUR2 function beyond sarcolemmal gating to subcellular trafficking and mitochondrial physiology.","evidence":"Immunofluorescence, surface HA-tag labeling, subcellular fractionation of rat hearts, fluorescence-based mitochondrial assays in SUR2-mutant mice","pmids":["20971764","20935152"],"confidence":"High","gaps":["Molecular mechanism of ischemia-induced trafficking not defined","Whether SUR2 is physically present in mitochondrial membranes vs. indirectly affecting mitochondria was debated"]},{"year":2012,"claim":"Identification of dominant ABCC9 gain-of-function mutations as the cause of Cantú syndrome, with mutations clustering in transmembrane domains and reducing ATP-mediated inhibition of KATP channels, established a new Mendelian channelopathy paradigm for SUR2.","evidence":"Exome sequencing of multiple affected families, Sanger validation, electrophysiological measurements of mutant channel ATP sensitivity","pmids":["22610116","22608503"],"confidence":"High","gaps":["How different Cantú mutations produce common phenotype despite distinct gating effects unknown","Tissue-specific pathophysiology (cardiac vs. vascular vs. skeletal) not dissected"]},{"year":2014,"claim":"Abcc9 exon 5 knockout mice revealed that SUR2 is required for the neonatal heart's metabolic transition from glycolysis to fatty acid oxidation, with loss causing mitochondrial immaturity and neonatal cardiomyopathy, establishing a developmental metabolic role for KATP channels.","evidence":"Exon 5 knockout mice, fatty acid oxidation assays, oxygen consumption measurements, electron microscopy of cardiac mitochondria","pmids":["24648545"],"confidence":"High","gaps":["Whether sarcolemmal or mitochondrial KATP (or both) drive metabolic maturation not resolved","Upstream transcriptional regulators of neonatal ABCC9 expression unknown"]},{"year":2015,"claim":"Detailed electrophysiological dissection of multiple Cantú syndrome mutations revealed at least two distinct gain-of-function mechanisms: enhanced MgADP activation versus reduced ATP/glibenclamide sensitivity, showing that different mutations converge on channel overactivity through separate gating pathways.","evidence":"86Rb efflux assays and inside-out patch-clamp of engineered mutant SUR2A/Kir6.2 channels","pmids":["26621776"],"confidence":"High","gaps":["Whether mixed-mechanism mutations produce different disease severity not tested","Structural basis for mechanistic divergence unknown at the time"]},{"year":2019,"claim":"Discovery that homozygous ABCC9 loss-of-function causes AIMS (intellectual disability, myopathy, cardiac dysfunction) in humans, confirmed across mice and zebrafish, completed the allelic series from gain-of-function (Cantú) to loss-of-function and demonstrated SUR2 is essential for muscle and brain function.","evidence":"Patient exome sequencing, recombinant channel electrophysiology showing non-functional channels, SUR2 knockout mouse and zebrafish phenotyping","pmids":["31575858"],"confidence":"High","gaps":["CNS pathophysiology mechanism not defined","Whether residual SUR2 splice variants modulate AIMS severity unknown"]},{"year":2021,"claim":"Cantú syndrome knockin mouse models revealed that the R1154Q mutation causes near-complete SUR2 protein loss through aberrant mRNA splicing rather than altered gating, and that SUR2[A478V] gain-of-function in skeletal muscle causes atrophy through upregulation of ubiquitin ligases, connecting KATP overactivity to muscle wasting pathways.","evidence":"CRISPR knockin mice, cDNA sequencing, recombinant channel expression, hiPSC-derived cardiomyocytes, skeletal muscle patch-clamp, histopathology, and qPCR of atrophy markers","pmids":["33529173","34359961"],"confidence":"High","gaps":["Why R1154Q missense causes mis-splicing at the pre-mRNA level is mechanistically unexplained","Downstream signaling from KATP overactivity to atrogin-1/MuRF1 induction not mapped"]},{"year":2022,"claim":"Cryo-EM structures of SUR2A and SUR2B with KATP openers and Mg-nucleotides identified a common drug-binding pocket between TMD1 and TMD2 and showed that openers synergize with Mg-nucleotides to stabilize the NBD-dimerized occluded activating conformation, providing the first atomic-level mechanism of KATP opener action on SUR2.","evidence":"Cryo-EM structure determination of SUR2A and SUR2B with bound P1075 or levcromakalim","pmids":["35562524"],"confidence":"High","gaps":["Transition-state intermediates between inward-facing and occluded conformations not captured","Structures of disease-mutant SUR2 not yet determined"]},{"year":2022,"claim":"KCNJ8/ABCC9-containing KATP channels were shown to cell-autonomously regulate brain vascular smooth muscle cell differentiation through modulation of Ca2+ oscillations via voltage-dependent calcium channels, extending SUR2 function to developmental vascular biology.","evidence":"Kcnj8 KO mice, zebrafish models, chemical KATP modulation, live Ca2+ imaging, VSMC differentiation assays","pmids":["35588738"],"confidence":"High","gaps":["Transcriptional targets downstream of Ca2+ oscillation changes not identified","Relative contribution of SUR2 vs. Kir6.1 to differentiation signal not separated"]},{"year":2024,"claim":"Synthesis of structural data revealed a unique SUR2-specific regulatory helix (R-helix) absent in SUR1 that mediates Mg-ADP-induced channel activation, and confirmed that the C-terminal 42 residues allosterically regulate Mg-nucleotide binding kinetics on NBD2, unifying decades of pharmacological and mutagenesis data into a coherent conformational gating model.","evidence":"Review and synthesis of cryo-EM structural studies with functional validation","pmids":["38227376"],"confidence":"Medium","gaps":["R-helix deletion/mutation experiments in full-length SUR2 not reported","Dynamic conformational pathway from R-helix release to pore opening not resolved"]},{"year":2025,"claim":"The H60Y Cantú syndrome mutation was shown to cause gain-of-function selectively in Kir6.1-SUR2B but not Kir6.2-SUR2B channels, with valine 334 in the Kir6.1 C-terminus identified as the determinant, establishing that ABCC9 disease mutations can exploit pore-subunit isoform differences to produce tissue-selective pathophysiology.","evidence":"Membrane potential assays with chimeric Kir6.1/Kir6.2-SUR2 channels, site-directed mutagenesis","pmids":["41448431"],"confidence":"High","gaps":["In vivo tissue-selective phenotype of H60Y not yet characterized","Structural basis of Val334-mediated isoform selectivity not determined"]},{"year":null,"claim":"Key unresolved questions include: the identity and physiological role of a bona fide mitochondrial KATP channel containing SUR2 splice variants; the structural basis of disease-mutant SUR2 conformations; the signaling pathways linking KATP overactivity to skeletal muscle atrophy; and the mechanism by which SUR2 contributes to brain function as revealed by AIMS intellectual disability.","evidence":"","pmids":[],"confidence":"Low","gaps":["Mitochondrial KATP molecular composition remains unresolved","No structural data for disease-mutant SUR2","CNS mechanism of AIMS intellectual disability undefined","Signaling cascade from KATP to atrogin-1/MuRF1 not mapped"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140657","term_label":"ATP-dependent activity","supporting_discovery_ids":[5,7,14,18]},{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[0,1,4,11,17,18,24]},{"term_id":"GO:0005215","term_label":"transporter activity","supporting_discovery_ids":[0,8,11]}],"localization":[{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[0,8,24]},{"term_id":"GO:0005768","term_label":"endosome","supporting_discovery_ids":[8]},{"term_id":"GO:0005739","term_label":"mitochondrion","supporting_discovery_ids":[9,16]}],"pathway":[{"term_id":"R-HSA-382551","term_label":"Transport of small molecules","supporting_discovery_ids":[0,1,11,24]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[2,3,25]},{"term_id":"R-HSA-1643685","term_label":"Disease","supporting_discovery_ids":[5,11,17,20]},{"term_id":"R-HSA-1430728","term_label":"Metabolism","supporting_discovery_ids":[2,16]}],"complexes":["KATP channel (SUR2A/Kir6.2)","KATP channel (SUR2B/Kir6.2)","KATP channel (SUR2B/Kir6.1)"],"partners":["KCNJ11","KCNJ8"],"other_free_text":[]},"mechanistic_narrative":"ABCC9 encodes the sulfonylurea receptor 2 (SUR2), the regulatory subunit of ATP-sensitive potassium (KATP) channels that couples cellular metabolic status to membrane excitability in cardiac, skeletal, and vascular smooth muscle [PMID:8826984]. SUR2 assembles with Kir6.x pore-forming subunits into heterooctameric channels whose gating is controlled by asymmetric NBD1/NBD2 nucleotide-binding domains: Mg-ATP inhibits and Mg-ADP activates channel opening through a unique regulatory helix (R-helix) release mechanism, while the alternatively spliced C-terminal 42 residues allosterically tune NBD2 nucleotide sensing and drug selectivity [PMID:18311911, PMID:9692785, PMID:38227376]. K-channel opener drugs bind a transmembrane pocket between TMD1 and TMD2 to stabilize the NBD-dimerized occluded activating state, and SUR2 also directs KATP channel trafficking between endosomal and sarcolemmal compartments and participates in neonatal cardiac metabolic maturation from glycolysis to fatty acid oxidation [PMID:35562524, PMID:20971764, PMID:24648545]. Loss-of-function mutations cause AIMS (intellectual disability, myopathy, cardiac dysfunction), gain-of-function mutations cause Cantú syndrome and cardiac arrhythmias including Brugada and early repolarization syndromes, and vascular SUR2 loss produces coronary vasospasm and hypertension [PMID:31575858, PMID:22610116, PMID:24439875, PMID:12122112]."},"prefetch_data":{"uniprot":{"accession":"O60706","full_name":"ATP-binding cassette sub-family C member 9","aliases":["Sulfonylurea receptor 2"],"length_aa":1549,"mass_kda":174.2,"function":"Subunit of ATP-sensitive potassium channels (KATP). Can form cardiac and smooth muscle-type KATP channels with KCNJ11. KCNJ11 forms the channel pore while ABCC9 is required for activation and regulation (PubMed:9831708). Can form a sulfonylurea-sensitive but ATP-insensitive potassium channel with KCNJ8 (By similarity)","subcellular_location":"Membrane","url":"https://www.uniprot.org/uniprotkb/O60706/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/ABCC9","classification":"Not Classified","n_dependent_lines":0,"n_total_lines":1208,"dependency_fraction":0.0},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/ABCC9","total_profiled":1310},"omim":[{"mim_id":"619719","title":"INTELLECTUAL DISABILITY AND MYOPATHY SYNDROME; IDMYS","url":"https://www.omim.org/entry/619719"},{"mim_id":"614050","title":"ATRIAL FIBRILLATION, FAMILIAL, 12; ATFB12","url":"https://www.omim.org/entry/614050"},{"mim_id":"608583","title":"ATRIAL FIBRILLATION, FAMILIAL, 1; ATFB1","url":"https://www.omim.org/entry/608583"},{"mim_id":"608569","title":"CARDIOMYOPATHY, DILATED, 1O; CMD1O","url":"https://www.omim.org/entry/608569"},{"mim_id":"608089","title":"ENDOMETRIAL CANCER","url":"https://www.omim.org/entry/608089"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Approved","locations":[{"location":"Nucleoplasm","reliability":"Approved"},{"location":"Plasma membrane","reliability":"Approved"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in many","driving_tissues":[],"url":"https://www.proteinatlas.org/search/ABCC9"},"hgnc":{"alias_symbol":["SUR2","CMD1O"],"prev_symbol":[]},"alphafold":{"accession":"O60706","domains":[{"cath_id":"-","chopping":"11-214","consensus_level":"high","plddt":86.2299,"start":11,"end":214},{"cath_id":"3.40.50.300","chopping":"689-733_751-926","consensus_level":"high","plddt":82.4456,"start":689,"end":926}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/O60706","model_url":"https://alphafold.ebi.ac.uk/files/AF-O60706-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-O60706-F1-predicted_aligned_error_v6.png","plddt_mean":81.69},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=ABCC9","jax_strain_url":"https://www.jax.org/strain/search?query=ABCC9"},"sequence":{"accession":"O60706","fasta_url":"https://rest.uniprot.org/uniprotkb/O60706.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/O60706/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/O60706"}},"corpus_meta":[{"pmid":"15034580","id":"PMC_15034580","title":"ABCC9 mutations identified in human dilated cardiomyopathy disrupt catalytic KATP channel gating.","date":"2004","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/15034580","citation_count":286,"is_preprint":false},{"pmid":"8826984","id":"PMC_8826984","title":"Cloning, tissue expression, and chromosomal localization of SUR2, the putative drug-binding subunit of cardiac, skeletal muscle, and vascular KATP channels.","date":"1996","source":"Diabetes","url":"https://pubmed.ncbi.nlm.nih.gov/8826984","citation_count":224,"is_preprint":false},{"pmid":"11934987","id":"PMC_11934987","title":"Transcription control by E1A and MAP kinase pathway via Sur2 mediator subunit.","date":"2002","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/11934987","citation_count":211,"is_preprint":false},{"pmid":"11114200","id":"PMC_11114200","title":"The SUR2 gene of Arabidopsis thaliana encodes the cytochrome P450 CYP83B1, a modulator of auxin homeostasis.","date":"2000","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/11114200","citation_count":207,"is_preprint":false},{"pmid":"12122112","id":"PMC_12122112","title":"Episodic coronary artery vasospasm and hypertension develop in the absence of Sur2 K(ATP) channels.","date":"2002","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/12122112","citation_count":198,"is_preprint":false},{"pmid":"9675903","id":"PMC_9675903","title":"Sur2 mutations of Arabidopsis thaliana define a new locus involved in the control of auxin homeostasis.","date":"1998","source":"The Plant journal : for cell and molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/9675903","citation_count":192,"is_preprint":false},{"pmid":"22610116","id":"PMC_22610116","title":"Dominant missense mutations in ABCC9 cause Cantú syndrome.","date":"2012","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/22610116","citation_count":160,"is_preprint":false},{"pmid":"22608503","id":"PMC_22608503","title":"Cantú syndrome is caused by mutations in ABCC9.","date":"2012","source":"American journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/22608503","citation_count":132,"is_preprint":false},{"pmid":"7557379","id":"PMC_7557379","title":"sur-2, a novel gene, functions late in the let-60 ras-mediated signaling pathway during Caenorhabditis elegans vulval induction.","date":"1995","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/7557379","citation_count":107,"is_preprint":false},{"pmid":"24439875","id":"PMC_24439875","title":"ABCC9 is a novel Brugada and early repolarization syndrome susceptibility gene.","date":"2014","source":"International journal of cardiology","url":"https://pubmed.ncbi.nlm.nih.gov/24439875","citation_count":104,"is_preprint":false},{"pmid":"11562480","id":"PMC_11562480","title":"Disruption of Sur2-containing K(ATP) channels enhances insulin-stimulated glucose uptake in skeletal muscle.","date":"2001","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/11562480","citation_count":96,"is_preprint":false},{"pmid":"24770881","id":"PMC_24770881","title":"ABCC9 gene polymorphism is associated with hippocampal sclerosis of aging pathology.","date":"2014","source":"Acta neuropathologica","url":"https://pubmed.ncbi.nlm.nih.gov/24770881","citation_count":76,"is_preprint":false},{"pmid":"9692785","id":"PMC_9692785","title":"SUR2 subtype (A and B)-dependent differential activation of the cloned ATP-sensitive K+ channels by pinacidil and nicorandil.","date":"1998","source":"British journal of pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/9692785","citation_count":73,"is_preprint":false},{"pmid":"32382014","id":"PMC_32382014","title":"TRIM11 facilitates chemoresistance in nasopharyngeal carcinoma by activating the β-catenin/ABCC9 axis via p62-selective autophagic degradation of Daple.","date":"2020","source":"Oncogenesis","url":"https://pubmed.ncbi.nlm.nih.gov/32382014","citation_count":73,"is_preprint":false},{"pmid":"12130541","id":"PMC_12130541","title":"C. elegans EOR-1/PLZF and EOR-2 positively regulate Ras and Wnt signaling and function redundantly with LIN-25 and the SUR-2 Mediator component.","date":"2002","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/12130541","citation_count":72,"is_preprint":false},{"pmid":"25470345","id":"PMC_25470345","title":"Reassessment of risk genotypes (GRN, TMEM106B, and ABCC9 variants) associated with hippocampal sclerosis of aging pathology.","date":"2015","source":"Journal of neuropathology and experimental neurology","url":"https://pubmed.ncbi.nlm.nih.gov/25470345","citation_count":66,"is_preprint":false},{"pmid":"26226329","id":"PMC_26226329","title":"ABCC9/SUR2 in the brain: Implications for hippocampal sclerosis of aging and a potential therapeutic target.","date":"2015","source":"Ageing research reviews","url":"https://pubmed.ncbi.nlm.nih.gov/26226329","citation_count":62,"is_preprint":false},{"pmid":"34526147","id":"PMC_34526147","title":"Analysis of genes (TMEM106B, GRN, ABCC9, KCNMB2, and APOE) implicated in risk for LATE-NC and hippocampal sclerosis provides pathogenetic insights: a retrospective genetic association study.","date":"2021","source":"Acta neuropathologica communications","url":"https://pubmed.ncbi.nlm.nih.gov/34526147","citation_count":47,"is_preprint":false},{"pmid":"17765261","id":"PMC_17765261","title":"Mice lacking sulfonylurea receptor 2 (SUR2) ATP-sensitive potassium channels are resistant to acute cardiovascular stress.","date":"2007","source":"Journal of molecular and cellular cardiology","url":"https://pubmed.ncbi.nlm.nih.gov/17765261","citation_count":39,"is_preprint":false},{"pmid":"20971764","id":"PMC_20971764","title":"Endosomal KATP channels as a reservoir after myocardial ischemia: a role for SUR2 subunits.","date":"2010","source":"American journal of physiology. Heart and circulatory physiology","url":"https://pubmed.ncbi.nlm.nih.gov/20971764","citation_count":39,"is_preprint":false},{"pmid":"35588738","id":"PMC_35588738","title":"KCNJ8/ABCC9-containing K-ATP channel modulates brain vascular smooth muscle development and neurovascular coupling.","date":"2022","source":"Developmental cell","url":"https://pubmed.ncbi.nlm.nih.gov/35588738","citation_count":36,"is_preprint":false},{"pmid":"31575858","id":"PMC_31575858","title":"ABCC9-related Intellectual disability Myopathy Syndrome is a KATP channelopathy with loss-of-function mutations in ABCC9.","date":"2019","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/31575858","citation_count":36,"is_preprint":false},{"pmid":"11909819","id":"PMC_11909819","title":"Intramolecular interaction of SUR2 subtypes for intracellular ADP-Induced differential control of K(ATP) channels.","date":"2002","source":"Circulation research","url":"https://pubmed.ncbi.nlm.nih.gov/11909819","citation_count":34,"is_preprint":false},{"pmid":"26621776","id":"PMC_26621776","title":"Differential mechanisms of Cantú syndrome-associated gain of function mutations in the ABCC9 (SUR2) subunit of the KATP channel.","date":"2015","source":"The Journal of general physiology","url":"https://pubmed.ncbi.nlm.nih.gov/26621776","citation_count":33,"is_preprint":false},{"pmid":"11054556","id":"PMC_11054556","title":"Molecular characterization of human SUR2-containing K(ATP) channels.","date":"2000","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/11054556","citation_count":29,"is_preprint":false},{"pmid":"32457608","id":"PMC_32457608","title":"Repurposing Kir6/SUR2 Channel Activator Minoxidil to Arrests Growth of Gynecologic Cancers.","date":"2020","source":"Frontiers in pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/32457608","citation_count":28,"is_preprint":false},{"pmid":"28131462","id":"PMC_28131462","title":"Gene-based association study of genes linked to hippocampal sclerosis of aging neuropathology: GRN, TMEM106B, ABCC9, and KCNMB2.","date":"2017","source":"Neurobiology of aging","url":"https://pubmed.ncbi.nlm.nih.gov/28131462","citation_count":27,"is_preprint":false},{"pmid":"23739550","id":"PMC_23739550","title":"Coronary spasm and acute myocardial infarction due to a mutation (V734I) in the nucleotide binding domain 1 of ABCC9.","date":"2013","source":"International journal of cardiology","url":"https://pubmed.ncbi.nlm.nih.gov/23739550","citation_count":26,"is_preprint":false},{"pmid":"33170808","id":"PMC_33170808","title":"Kir6.1- and SUR2-dependent KATP overactivity disrupts intestinal motility in murine models of Cantú syndrome.","date":"2020","source":"JCI insight","url":"https://pubmed.ncbi.nlm.nih.gov/33170808","citation_count":25,"is_preprint":false},{"pmid":"16563363","id":"PMC_16563363","title":"A novel Val734Ile variant in the ABCC9 gene associated with myocardial infarction.","date":"2006","source":"Clinica chimica acta; international journal of clinical chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/16563363","citation_count":25,"is_preprint":false},{"pmid":"18311911","id":"PMC_18311911","title":"Interaction of asymmetric ABCC9-encoded nucleotide binding domains determines KATP channel SUR2A catalytic activity.","date":"2008","source":"Journal of proteome research","url":"https://pubmed.ncbi.nlm.nih.gov/18311911","citation_count":24,"is_preprint":false},{"pmid":"23307537","id":"PMC_23307537","title":"Wide clinical variability in conditions with coarse facial features and hypertrichosis caused by mutations in ABCC9.","date":"2013","source":"American journal of medical genetics. Part A","url":"https://pubmed.ncbi.nlm.nih.gov/23307537","citation_count":23,"is_preprint":false},{"pmid":"22844491","id":"PMC_22844491","title":"Promoter DNA methylation regulates murine SUR1 (Abcc8) and SUR2 (Abcc9) expression in HL-1 cardiomyocytes.","date":"2012","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/22844491","citation_count":22,"is_preprint":false},{"pmid":"26115089","id":"PMC_26115089","title":"Novel human ABCC9/SUR2 brain-expressed transcripts and an eQTL relevant to hippocampal sclerosis of aging.","date":"2015","source":"Journal of neurochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/26115089","citation_count":18,"is_preprint":false},{"pmid":"24648545","id":"PMC_24648545","title":"Abcc9 is required for the transition to oxidative metabolism in the newborn heart.","date":"2014","source":"FASEB journal : official publication of the Federation of American Societies for Experimental Biology","url":"https://pubmed.ncbi.nlm.nih.gov/24648545","citation_count":18,"is_preprint":false},{"pmid":"15542641","id":"PMC_15542641","title":"Requirement of Sur2 for efficient replication of mouse adenovirus type 1.","date":"2004","source":"Journal of virology","url":"https://pubmed.ncbi.nlm.nih.gov/15542641","citation_count":17,"is_preprint":false},{"pmid":"26871653","id":"PMC_26871653","title":"De Novo Mutation in ABCC9 Causes Hypertrichosis Acromegaloid Facial Features Disorder.","date":"2016","source":"Pediatric dermatology","url":"https://pubmed.ncbi.nlm.nih.gov/26871653","citation_count":17,"is_preprint":false},{"pmid":"34359961","id":"PMC_34359961","title":"Consequences of SUR2[A478V] Mutation in Skeletal Muscle of Murine Model of Cantu Syndrome.","date":"2021","source":"Cells","url":"https://pubmed.ncbi.nlm.nih.gov/34359961","citation_count":15,"is_preprint":false},{"pmid":"33529173","id":"PMC_33529173","title":"Complex consequences of Cantu syndrome SUR2 variant R1154Q in genetically modified mice.","date":"2021","source":"JCI insight","url":"https://pubmed.ncbi.nlm.nih.gov/33529173","citation_count":15,"is_preprint":false},{"pmid":"35562524","id":"PMC_35562524","title":"Structural identification of vasodilator binding sites on the SUR2 subunit.","date":"2022","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/35562524","citation_count":13,"is_preprint":false},{"pmid":"34575427","id":"PMC_34575427","title":"Zoledronic Acid as a Novel Dual Blocker of KIR6.1/2-SUR2 Subunits of ATP-Sensitive K+ Channels: Role in the Adverse Drug Reactions.","date":"2021","source":"Pharmaceutics","url":"https://pubmed.ncbi.nlm.nih.gov/34575427","citation_count":13,"is_preprint":false},{"pmid":"15116344","id":"PMC_15116344","title":"Cloning and functional characterization of the SUR2/SYR2 gene encoding sphinganine hydroxylase in Pichia ciferrii.","date":"2004","source":"Yeast (Chichester, England)","url":"https://pubmed.ncbi.nlm.nih.gov/15116344","citation_count":12,"is_preprint":false},{"pmid":"21784985","id":"PMC_21784985","title":"Vasodilation induced by oxygen/glucose deprivation is attenuated in cerebral arteries of SUR2 null mice.","date":"2011","source":"American journal of physiology. Heart and circulatory physiology","url":"https://pubmed.ncbi.nlm.nih.gov/21784985","citation_count":12,"is_preprint":false},{"pmid":"20935152","id":"PMC_20935152","title":"The mitochondrial bioenergetic phenotype for protection from cardiac ischemia in SUR2 mutant mice.","date":"2010","source":"American journal of physiology. Heart and circulatory physiology","url":"https://pubmed.ncbi.nlm.nih.gov/20935152","citation_count":12,"is_preprint":false},{"pmid":"38217872","id":"PMC_38217872","title":"Novel loss-of-function variants expand ABCC9-related intellectual disability and myopathy syndrome.","date":"2024","source":"Brain : a journal of neurology","url":"https://pubmed.ncbi.nlm.nih.gov/38217872","citation_count":9,"is_preprint":false},{"pmid":"32309617","id":"PMC_32309617","title":"A rare case of familial restrictive cardiomyopathy, with mutations in MYH7 and ABCC9 genes.","date":"2019","source":"Discoveries (Craiova, Romania)","url":"https://pubmed.ncbi.nlm.nih.gov/32309617","citation_count":9,"is_preprint":false},{"pmid":"24037327","id":"PMC_24037327","title":"ATP-sensitive potassium currents from channels formed by Kir6 and a modified cardiac mitochondrial SUR2 variant.","date":"2013","source":"Channels (Austin, Tex.)","url":"https://pubmed.ncbi.nlm.nih.gov/24037327","citation_count":9,"is_preprint":false},{"pmid":"34114004","id":"PMC_34114004","title":"Identification of sur2 mutation affecting the lifespan of fission yeast.","date":"2021","source":"FEMS microbiology letters","url":"https://pubmed.ncbi.nlm.nih.gov/34114004","citation_count":8,"is_preprint":false},{"pmid":"32622958","id":"PMC_32622958","title":"Cantú syndrome versus Zimmermann-Laband syndrome: Report of nine individuals with ABCC9 variants.","date":"2020","source":"European journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/32622958","citation_count":8,"is_preprint":false},{"pmid":"19952277","id":"PMC_19952277","title":"Genes controlling postural changes in blood pressure: comprehensive association analysis of ATP-sensitive potassium channel genes KCNJ8 and ABCC9.","date":"2009","source":"Physiological genomics","url":"https://pubmed.ncbi.nlm.nih.gov/19952277","citation_count":8,"is_preprint":false},{"pmid":"37522618","id":"PMC_37522618","title":"Genetic Interaction between Arabidopsis SUR2/CYP83B1 and GNOM Indicates the Importance of Stabilizing Local Auxin Accumulation in Lateral Root Initiation.","date":"2023","source":"Plant & cell physiology","url":"https://pubmed.ncbi.nlm.nih.gov/37522618","citation_count":7,"is_preprint":false},{"pmid":"17395632","id":"PMC_17395632","title":"The Kir6.2-F333I mutation differentially modulates KATP channels composed of SUR1 or SUR2 subunits.","date":"2007","source":"The Journal of physiology","url":"https://pubmed.ncbi.nlm.nih.gov/17395632","citation_count":7,"is_preprint":false},{"pmid":"36704469","id":"PMC_36704469","title":"Involvement of SUR2/Kir6.1 channel in the physiopathology of pulmonary arterial hypertension.","date":"2023","source":"Frontiers in cardiovascular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/36704469","citation_count":6,"is_preprint":false},{"pmid":"37154692","id":"PMC_37154692","title":"Skeletal muscle delimited myopathy and verapamil toxicity in SUR2 mutant mouse models of AIMS.","date":"2023","source":"EMBO molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/37154692","citation_count":6,"is_preprint":false},{"pmid":"36336713","id":"PMC_36336713","title":"Lymphedema as first clinical presentation of Cantu Syndrome: reversed phenotyping after identification of gain-of-function variant in ABCC9.","date":"2022","source":"European journal of human genetics : EJHG","url":"https://pubmed.ncbi.nlm.nih.gov/36336713","citation_count":6,"is_preprint":false},{"pmid":"30878466","id":"PMC_30878466","title":"Functional characterization of ABCC9 variants identified in sudden unexpected natural death.","date":"2019","source":"Forensic science international","url":"https://pubmed.ncbi.nlm.nih.gov/30878466","citation_count":6,"is_preprint":false},{"pmid":"36980269","id":"PMC_36980269","title":"Zoledronic Acid Blocks Overactive Kir6.1/SUR2-Dependent KATP Channels in Skeletal Muscle and Osteoblasts in a Murine Model of Cantú Syndrome.","date":"2023","source":"Cells","url":"https://pubmed.ncbi.nlm.nih.gov/36980269","citation_count":4,"is_preprint":false},{"pmid":"35495129","id":"PMC_35495129","title":"Case Report: Loss-of-Function ABCC9 Genetic Variant Associated With Ventricular Fibrillation.","date":"2022","source":"Frontiers in genetics","url":"https://pubmed.ncbi.nlm.nih.gov/35495129","citation_count":2,"is_preprint":false},{"pmid":"34455535","id":"PMC_34455535","title":"Cardiac dysfunction in spontaneously hypertensive old rats is associated with a significant decrease of SUR2 expression.","date":"2021","source":"Molecular and cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/34455535","citation_count":2,"is_preprint":false},{"pmid":"39719180","id":"PMC_39719180","title":"Loss of SUR2 alters the composition of ceramides and shortens chronological lifespan of Saccharomyces cerevisiae.","date":"2024","source":"Biochimica et biophysica acta. Molecular and cell biology of lipids","url":"https://pubmed.ncbi.nlm.nih.gov/39719180","citation_count":2,"is_preprint":false},{"pmid":"28627835","id":"PMC_28627835","title":"Clinical and Molecular Delineation of a Novel Cys1050Phe Missense Mutation in the ABCC9 Gene in a Korean Patient with Cantú Syndrome.","date":"2017","source":"Clinical laboratory","url":"https://pubmed.ncbi.nlm.nih.gov/28627835","citation_count":2,"is_preprint":false},{"pmid":"38227376","id":"PMC_38227376","title":"Sulfonylurea receptor 2 (SUR2), intricate sensors for intracellular Mg-nucleotides.","date":"2024","source":"BioEssays : news and reviews in molecular, cellular and developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/38227376","citation_count":1,"is_preprint":false},{"pmid":"23464919","id":"PMC_23464919","title":"Expression and purification of a soluble ESX-binding core domain of SUR2.","date":"2013","source":"Preparative biochemistry & biotechnology","url":"https://pubmed.ncbi.nlm.nih.gov/23464919","citation_count":1,"is_preprint":false},{"pmid":"35071399","id":"PMC_35071399","title":"ABCC9 Is Downregulated and Prone to Microsatellite Instability on ABCC9tetra in Canine Breast Cancer.","date":"2022","source":"Frontiers in veterinary science","url":"https://pubmed.ncbi.nlm.nih.gov/35071399","citation_count":0,"is_preprint":false},{"pmid":"41347799","id":"PMC_41347799","title":"ABCC9 knockdown attenuates isoproterenol‑induced myocardial hypertrophy by inhibiting the PI3K/AKT signaling pathway.","date":"2025","source":"Molecular medicine reports","url":"https://pubmed.ncbi.nlm.nih.gov/41347799","citation_count":0,"is_preprint":false},{"pmid":"40923965","id":"PMC_40923965","title":"Beyond Tachycardia-Induced Cardiomyopathy: ABCC9-Related Dilated Cardiomyopathy and Familial Atrial Fibrillation.","date":"2025","source":"JACC. Case reports","url":"https://pubmed.ncbi.nlm.nih.gov/40923965","citation_count":0,"is_preprint":false},{"pmid":"39344622","id":"PMC_39344622","title":"[Clinical characteristics and genetic analysis of a child with Cantú syndrome due to variant of ABCC9 gene].","date":"2024","source":"Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/39344622","citation_count":0,"is_preprint":false},{"pmid":"41448431","id":"PMC_41448431","title":"Cantu syndrome-associated SUR2[H60Y] mutation confers selective gain of function on Kir6.1 ATP-sensitive potassium channels.","date":"2025","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/41448431","citation_count":0,"is_preprint":false},{"pmid":"37239348","id":"PMC_37239348","title":"An ABCC9 Missense Variant Is Associated with Sudden Cardiac Death and Dilated Cardiomyopathy in Juvenile Dogs.","date":"2023","source":"Genes","url":"https://pubmed.ncbi.nlm.nih.gov/37239348","citation_count":0,"is_preprint":false},{"pmid":"39031464","id":"PMC_39031464","title":"A novel ABCC9 variant in a Greek family with Cantu syndrome affecting multiple generations highlights the functional role of the SUR2B NBD1.","date":"2024","source":"American journal of medical genetics. Part A","url":"https://pubmed.ncbi.nlm.nih.gov/39031464","citation_count":0,"is_preprint":false},{"pmid":"28774639","id":"PMC_28774639","title":"Draft genome sequence of Chryseobacterium limigenitum SUR2T (LMG 28734T) isolated from dehydrated sludge.","date":"2017","source":"Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology]","url":"https://pubmed.ncbi.nlm.nih.gov/28774639","citation_count":0,"is_preprint":false},{"pmid":null,"id":"bio_10.1101_2025.06.03.657619","title":"The <i>CYP71A</i> , <i>NIT</i> , <i>AMI,</i> and <i>IAMH</i> gene families are dispensable for indole-3-acetaldoxime-mediated auxin biosynthesis in Arabidopsis","date":"2025-06-06","source":"bioRxiv","url":"https://doi.org/10.1101/2025.06.03.657619","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2025.11.28.691118","title":"Uncoupling of nutrient sensing and cell size control by specific defects in ceramide structure","date":"2025-12-01","source":"bioRxiv","url":"https://doi.org/10.1101/2025.11.28.691118","citation_count":0,"is_preprint":true}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":36617,"output_tokens":6984,"usd":0.107305},"stage2":{"model":"claude-opus-4-6","input_tokens":10657,"output_tokens":4338,"usd":0.242602},"total_usd":0.349907,"stage1_batch_id":"msgbatch_01TqNM6p6FsoMBT2jzQTwKBr","stage2_batch_id":"msgbatch_01Ya473eco8sTHbvRymQaU8o","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1996,\n      \"finding\": \"ABCC9 encodes SUR2A and SUR2B, alternatively spliced isoforms of the sulfonylurea receptor that form the regulatory subunit of cardiac, skeletal muscle, and vascular KATP channels by partnering with the inwardly rectifying K+ channel subunit KIR6.2; SUR2A is expressed exclusively in heart while SUR2B is ubiquitous.\",\n      \"method\": \"cDNA cloning, Northern blotting, RT-PCR, in situ hybridization, FISH chromosomal localization\",\n      \"journal\": \"Diabetes\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods in foundational cloning paper, highly cited\",\n      \"pmids\": [\"8826984\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"The C-terminal 42 amino acid residues that differ between SUR2A and SUR2B determine subtype-selective pharmacological activation of KATP channels; nicorandil preferentially activates SUR2B/Kir6.2 channels (>100-fold lower EC50) over SUR2A/Kir6.2 channels, implicating the C-terminal tail in drug selectivity.\",\n      \"method\": \"Heterologous expression in HEK293T cells, patch-clamp electrophysiology (cell-attached and whole-cell configurations)\",\n      \"journal\": \"British journal of pharmacology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — reconstituted channel in heterologous system with quantitative pharmacology, replicated across SUR2 subtypes\",\n      \"pmids\": [\"9692785\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"Disruption of SUR2-containing KATP channels in skeletal muscle enhances insulin-stimulated glucose uptake, demonstrating that SUR2-dependent membrane excitability is a component of the insulin-stimulated glucose uptake mechanism.\",\n      \"method\": \"Gene-targeted Sur2 knockout mice, glucose tolerance tests, hyperinsulinemic euglycemic clamp, in vitro insulin-stimulated glucose transport assay in isolated muscle\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean KO with multiple defined physiological readouts, in vivo and in vitro\",\n      \"pmids\": [\"11562480\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"Sur2-containing KATP channels in vascular smooth muscle are critical regulators of episodic vasomotor activity; Sur2 null mice develop elevated resting blood pressure, sudden death, and episodic coronary artery vasospasm that is reversible by calcium channel antagonist treatment.\",\n      \"method\": \"Gene-targeted Sur2 knockout mice, in vivo hemodynamic monitoring, coronary angiography, pharmacological rescue with nifedipine\",\n      \"journal\": \"The Journal of clinical investigation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean KO with defined vascular phenotype, in vivo monitoring, pharmacological validation\",\n      \"pmids\": [\"12122112\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"The C-terminal 42 amino acid residues of SUR2 subtypes mediate intramolecular interaction with the second nucleotide-binding domain (NBD2), specifically a 7-residue segment that electrostatically interacts with Arg1344 at the Walker-A loop of NBD2, determining ADP-induced differential activation of KATP channels in SUR2A vs SUR2B.\",\n      \"method\": \"Chimeric SUR2A/SUR2B constructs expressed with Kir6.2, patch-clamp electrophysiology, 3D structural modeling based on HisP crystal structure\",\n      \"journal\": \"Circulation research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — chimeric mutant analysis with electrophysiology plus structural modeling; single lab\",\n      \"pmids\": [\"11909819\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"Two ABCC9 missense and frameshift mutations identified in dilated cardiomyopathy patients map to conserved domains adjacent to the catalytic ATPase pocket within SUR2A, causing aberrant redistribution of conformations in the intrinsic ATP hydrolytic cycle that translates into abnormal KATP channel phenotypes with compromised metabolic signal decoding.\",\n      \"method\": \"Genomic DNA scanning, functional expression of mutant SUR2A, electrophysiology (inside-out patch-clamp), ATPase activity assays\",\n      \"journal\": \"Nature genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro enzymatic and electrophysiology assays with disease mutations, multiple orthogonal methods\",\n      \"pmids\": [\"15034580\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"Conventional sarcolemmal cardiomyocyte KATP channels containing full-length SUR2 are not required for mediating cardioprotection against acute ischemia-reperfusion injury; SUR2 null mice show reduced infarct size, and nifedipine treatment to block baseline vasospasm reveals that the protection is partly vasospasm-dependent.\",\n      \"method\": \"SUR2 null mice, Langendorff-perfused heart ischemia model, infarct size measurement, nifedipine pharmacological dissection\",\n      \"journal\": \"Journal of molecular and cellular cardiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — clean KO with defined cardiac phenotype; single lab but multiple readouts\",\n      \"pmids\": [\"17765261\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"SUR2A contains asymmetric NBD1 and NBD2 domains; heterodomain NBD1/NBD2 interaction produces conformational rearrangements and enhances intrinsic ATPase activity. Mutation of the predicted catalytic base residue D834E in NBD1 alters NBD1 ATPase activity and disrupts potentiation of catalytic behavior, establishing NBD1/NBD2 assembly as the molecular basis for optimal SUR2A catalytic activity.\",\n      \"method\": \"Purified recombinant NBD1/NBD2 domains, dynamic light scattering, circular dichroism, atomic force microscopy, transmission electron microscopy, ATPase activity assays, site-directed mutagenesis\",\n      \"journal\": \"Journal of proteome research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — reconstitution with purified proteins, multiple structural methods, mutagenesis validation\",\n      \"pmids\": [\"18311911\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"SUR2 subunits are essential for trafficking KATP channels to an intracellular endosomal/lysosomal compartment; SUR2-containing channels dynamically cycle between endosomal and plasmalemmal compartments, and ischemia shifts this balance toward the sarcolemmal fraction, increasing surface KATP channel density without changing mRNA levels.\",\n      \"method\": \"Immunofluorescence microscopy, surface HA-tag labeling, subcellular fractionation of rat hearts, patch-clamp recording from ischemic ventricular myocytes\",\n      \"journal\": \"American journal of physiology. Heart and circulatory physiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal localization and functional methods; in vitro and ex vivo validation\",\n      \"pmids\": [\"20971764\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"SUR2 mutant mice have an altered mitochondrial phenotype including less polarized mitochondrial membrane potential, increased Ca2+ tolerance, enhanced ROS generation, and greater K+ influx compared to wild-type, consistent with SUR2 participation in mitochondrial KATP channel function and providing a basis for ischemic cardioprotection.\",\n      \"method\": \"Fluorescence-based assays of mitochondrial membrane potential, Ca2+ loading, ROS; light scattering volumetric assays; isolated mitochondria and intact myocyte experiments\",\n      \"journal\": \"American journal of physiology. Heart and circulatory physiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple mitochondrial assays in SUR2 mutant model; single lab\",\n      \"pmids\": [\"20935152\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"SUR2B is the sole SUR isoform expressed in murine cerebral artery smooth muscle cells, and SUR2-containing KATP channels mediate vasodilation induced by oxygen/glucose deprivation (OGD) and metabolic inhibition but not by hypoxia alone; loss of SUR2 impairs postischemic loss of myogenic tone.\",\n      \"method\": \"SUR2 null mice, pressurized cerebral artery myography, pinacidil pharmacology, hypoxia/OGD/metabolic inhibitor protocols, RT-PCR isoform identification\",\n      \"journal\": \"American journal of physiology. Heart and circulatory physiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic model with multiple pharmacological and physiological readouts, isoform identification\",\n      \"pmids\": [\"21784985\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"Dominant missense mutations in ABCC9 cause Cantú syndrome by reducing ATP-mediated inhibition of KATP channels, resulting in gain-of-function channel opening; all mutations alter amino acids in or near the transmembrane domains of SUR2.\",\n      \"method\": \"Exome sequencing of affected families, Sanger sequencing, electrophysiological measurements of mutant channel ATP sensitivity\",\n      \"journal\": \"Nature genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — direct electrophysiology of mutant channels; replicated across 16 individuals from multiple labs\",\n      \"pmids\": [\"22610116\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"Cantú syndrome ABCC9 mutations are heterozygous missense variants with a hotspot at Arg1154 within the second type 1 transmembrane region, consistent with an activating (gain-of-function) mechanism for KATP channels.\",\n      \"method\": \"Exome sequencing of proband-parent trios and unrelated cases, Sanger sequencing\",\n      \"journal\": \"American journal of human genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — genetic identification with mutation clustering at functional domain; no direct electrophysiology in this paper\",\n      \"pmids\": [\"22608503\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"CpG methylation of the ABCC9/SUR2 promoter region regulates SUR2 expression in HL-1 cardiomyocytes; 57.6% of CpGs in the SUR2 promoter are methylated versus 0.14% for SUR1, and demethylation with 5-aza-2'-deoxycytidine increases SUR2 mRNA expression.\",\n      \"method\": \"Bisulfite sequencing of genomic DNA, 5-aza-dC treatment, quantitative RT-PCR\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — bisulfite sequencing plus pharmacological demethylation with gene expression readout; single lab\",\n      \"pmids\": [\"22844491\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"The ABCC9 V734I mutation (in NBD1) selectively reduces MgATP inhibition and MgNDP activation of Kir6.2/SUR2B vascular channels but not Kir6.2/SUR2A cardiac or Kir6.1/SUR2B channels, linking impaired nucleotide sensing in vascular KATP channels to susceptibility to coronary vasospasm and myocardial infarction.\",\n      \"method\": \"Patch-clamp electrophysiology of recombinant channels in heterologous expression system, inside-out and whole-cell configurations\",\n      \"journal\": \"International journal of cardiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro electrophysiology with isoform-selective functional dissection; directly links mutation to channel mechanism\",\n      \"pmids\": [\"23739550\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"A SUR2A splice variant (SUR2A-55) lacking NBD1 and two transmembrane domains can co-assemble with Kir6.1 and Kir6.2 to form functional KATP channels with 70-fold reduced ATP sensitivity and markedly reduced drug sensitivity, suggesting it as a candidate mitoKATP regulatory subunit.\",\n      \"method\": \"Heterologous expression in COS cells, patch-clamp electrophysiology, pharmacological profiling with pinacidil/diazoxide/glibenclamide\",\n      \"journal\": \"Channels (Austin, Tex.)\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 — reconstituted channel with in vitro electrophysiology; single lab, candidate assignment remains speculative\",\n      \"pmids\": [\"24037327\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Abcc9 is required for the neonatal heart's transition from glycolytic to oxidative metabolism; deletion of exon 5 ablates both plasma membrane and mitochondria-associated Abcc9 proteins, causing neonatal cardiomyopathy with reduced fatty acid oxidation, reduced oxygen consumption, and mitochondrial immaturity.\",\n      \"method\": \"Exon 5 knockout mice, mitochondrial membrane potential assays, fatty acid oxidation assays, oxygen consumption measurements, electron microscopy of cardiac mitochondria, diazoxide KATP agonist testing\",\n      \"journal\": \"FASEB journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean KO with multiple orthogonal metabolic and morphological readouts; pharmacological dissection\",\n      \"pmids\": [\"24648545\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"ABCC9 gain-of-function mutations cause early repolarization and Brugada syndromes by increasing KATP channel activity; V734I-ABCC9 increases Mg-ATP IC50 5-fold and S1402C-ABCC9 shifts ATP IC50, both producing gain-of-function IK-ATP.\",\n      \"method\": \"Direct sequencing of susceptibility genes, whole-cell and inside-out patch-clamp in TSA201 cells expressing mutant SUR2A with Kir6.2\",\n      \"journal\": \"International journal of cardiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro electrophysiology with mutagenesis; multiple mutations characterized\",\n      \"pmids\": [\"24439875\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Three Cantú syndrome ABCC9 mutations (P432L, A478V, C1043Y) all produce gain-of-function KATP channels but through at least two distinct mechanisms: P429L and A475V enhance MgADP activation with normal ATP sensitivity, while C1039Y reduces sensitivity to both ATP inhibition and glibenclamide block without affecting MgADP activation.\",\n      \"method\": \"Rubidium efflux assays, inside-out patch-clamp electrophysiology; engineered mutations in rat SUR2A expressed with mouse Kir6.2\",\n      \"journal\": \"The Journal of general physiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — reconstituted channels, two orthogonal assays (86Rb efflux + patch-clamp), mechanistic dissection of multiple mutations\",\n      \"pmids\": [\"26621776\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"ABCC9 rs704180 risk allele functions as an expression quantitative trait locus (eQTL) in brain, associated with increased ABCC9 transcript levels and enrichment for a shorter 3' UTR; miR-30c down-regulates SUR2 transcripts with the longer 3' UTR.\",\n      \"method\": \"3' RACE of human brain cDNA, eQTL analysis across multiple brain expression databases, microRNA transfection experiments\",\n      \"journal\": \"Journal of neurochemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — miRNA transfection with expression readout; eQTL is associative but miRNA effect experimentally tested\",\n      \"pmids\": [\"26115089\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Homozygous loss-of-function splice-site mutation in ABCC9 (c.1320+1 G>A) causing in-frame deletion of exon 8 results in non-functional SUR2-containing KATP channels and produces a syndrome (AIMS) of intellectual disability, myopathy, and cardiac dysfunction; SUR2 loss-of-function causes fatigability and cardiac dysfunction in mice and zebrafish.\",\n      \"method\": \"Patient exome sequencing, recombinant channel expression with electrophysiology, SUR2 knockout mouse and zebrafish models with functional phenotyping\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — recombinant channel assay plus two in vivo model organisms with defined phenotypes\",\n      \"pmids\": [\"31575858\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"Kir6.1/SUR2-containing KATP channels underlie smooth muscle KATP throughout the intestine; gain-of-function mutations in Kir6.1/SUR2 (Cantú syndrome knockin mice) reduce intestinal contractility and cause GI dysmotility reversible by glibenclamide, a KATP inhibitor.\",\n      \"method\": \"Kir6.1/SUR2 knockin mice carrying human CS mutations, intestinal contractility assays, glibenclamide pharmacological rescue, subunit identification by genetic ablation\",\n      \"journal\": \"JCI insight\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — knockin mouse model with defined smooth muscle phenotype and pharmacological rescue\",\n      \"pmids\": [\"33170808\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"SUR2[A478V] gain-of-function knockin mutation reduces MgATP sensitivity of KATP currents in skeletal muscle fibers and causes muscle atrophy with up-regulation of atrogin-1 and MuRF1 mRNA, linking KATP overactivity to skeletal muscle atrophy in Cantú syndrome.\",\n      \"method\": \"Heterozygous and homozygous SUR2[A478V] knockin mice, patch-clamp of Flexor digitorum brevis fibers, muscle histopathology, qPCR of atrophy markers\",\n      \"journal\": \"Cells\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — knockin model with patch-clamp, histology, and molecular markers; multiple orthogonal readouts\",\n      \"pmids\": [\"34359961\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"SUR2[R1154Q] Cantú syndrome mutation causes near-complete loss of SUR2 protein and KATP channel activity in homozygous ventricular tissue due to aberrant splicing (in-frame deletion of exon 28 in ~90% of transcripts from homozygous tissue), revealing that ABCC9 mutations can act through mRNA mis-splicing rather than purely by altered channel gating.\",\n      \"method\": \"CRISPR/Cas9 knockin mice, cDNA sequencing, recombinant expression of SUR2A lacking exon 28, patch-clamp electrophysiology, hiPSC-derived cardiomyocyte analysis\",\n      \"journal\": \"JCI insight\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — CRISPR knockin plus recombinant channel expression plus human iPSC; multiple orthogonal methods\",\n      \"pmids\": [\"33529173\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"Cryo-EM structures of SUR2A and SUR2B in complex with Mg-nucleotides and KATP openers P1075 or levcromakalim reveal that both vasodilators bind a common site in the transmembrane domain between TMD1 and TMD2 (embraced by TM10, TM11, TM12, TM14, and TM17), and synergize with Mg-nucleotides to stabilize SUR2 in the NBD-dimerized occluded state to activate the channel.\",\n      \"method\": \"Cryo-EM structure determination of SUR2A and SUR2B with bound ligands\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — cryo-EM structures at high resolution identifying specific drug binding site and conformational mechanism\",\n      \"pmids\": [\"35562524\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"KCNJ8/ABCC9-containing KATP channels cell-autonomously regulate brain vascular smooth muscle cell (VSMC) differentiation through modulation of intracellular Ca2+ oscillation via voltage-dependent calcium channels; loss or gain of KATP function suppresses or promotes arterial VSMC differentiation, and Kcnj8 KO mice show deficient vasoconstrictive capacity and impaired neurovascular coupling.\",\n      \"method\": \"Kcnj8 KO mice, zebrafish genetic models, chemical KATP inhibition/activation, live imaging of Ca2+ oscillations, VSMC differentiation assays in cell culture\",\n      \"journal\": \"Developmental cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple model systems (mouse, zebrafish, cell culture), live Ca2+ imaging, genetic and pharmacological dissection\",\n      \"pmids\": [\"35588738\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"Loss of SUR2 in skeletal muscle specifically underlies myopathy in AIMS; ABCC9 loss-of-function results in abnormal generation of unstimulated forces in isolated muscle, and CaV1.1 channel blockade by verapamil causes premature death in AIMS mice, indicating Ca2+ influx through CaV1.1 is not the primary pathological mechanism.\",\n      \"method\": \"Tissue-selective KATP suppression with premature stop codon mouse models, isolated muscle force measurements, verapamil pharmacological intervention, CaV1.1 non-permeable mutant genetic rescue\",\n      \"journal\": \"EMBO molecular medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — tissue-selective genetic model, isolated muscle physiology, pharmacological and genetic rescue experiments\",\n      \"pmids\": [\"37154692\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"SUR2 undergoes ligand-dependent dynamic conformational changes between an inhibitory inward-facing conformation and an activating occluded conformation; Mg-ADP binding to NBD2 competes with inhibitory Mg-ATP to promote release of a unique inhibitory Regulatory helix (R helix) absent in SUR1, initiating channel activation; the C-terminal 42 residues (C42) allosterically regulate Mg-nucleotide binding kinetics on NBD2.\",\n      \"method\": \"Structural studies (cryo-EM) with functional validation (referenced as 'recent structural studies')\",\n      \"journal\": \"BioEssays : news and reviews in molecular, cellular and developmental biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 — based on structural data; this is a review/synthesis paper citing recent cryo-EM work, so primary data in cited structural papers\",\n      \"pmids\": [\"38227376\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"SUR2[H60Y] Cantú syndrome mutation causes gain-of-function selectively in Kir6.1-SUR2B channels but not Kir6.2-SUR2B channels; chimeric and mutagenesis analysis identifies the N and C termini of Kir6.1 and specifically valine 334 in Kir6.1 as necessary for this isoform-specific GOF effect.\",\n      \"method\": \"DiBAC4(3) membrane potential measurements in intact cells expressing Kir6.1/Kir6.2-SUR2 combinations, chimeric channel approach, site-directed mutagenesis of Kir6.1\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — mutagenesis and chimeric constructs with functional assay; mechanistic dissection of isoform specificity\",\n      \"pmids\": [\"41448431\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"ABCC9 encodes SUR2 (SUR2A and SUR2B splice isoforms), the regulatory subunit of ATP-sensitive potassium (KATP) channels that couples cellular metabolic state to membrane excitability: SUR2 assembles with Kir6.x pore-forming subunits into heterooctameric KATP complexes in cardiac, skeletal, and vascular smooth muscle; its asymmetric NBD1/NBD2 domains catalyze ATP hydrolysis and sense Mg-nucleotides (Mg-ATP inhibitory, Mg-ADP activating via a unique R-helix release mechanism), K+ channel opener drugs bind a transmembrane domain site between TMD1 and TMD2 to stabilize the NBD-dimerized occluded activating state, and loss-of-function or gain-of-function mutations cause a spectrum of diseases (dilated cardiomyopathy, Cantú syndrome, AIMS) by respectively preventing or constitutively enabling channel opening, while SUR2 also directs KATP channel trafficking to endosomal compartments and participates in mitochondrial metabolism and neonatal cardiac metabolic maturation.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"ABCC9 encodes the sulfonylurea receptor 2 (SUR2), the regulatory subunit of ATP-sensitive potassium (KATP) channels that couples cellular metabolic status to membrane excitability in cardiac, skeletal, and vascular smooth muscle [PMID:8826984]. SUR2 assembles with Kir6.x pore-forming subunits into heterooctameric channels whose gating is controlled by asymmetric NBD1/NBD2 nucleotide-binding domains: Mg-ATP inhibits and Mg-ADP activates channel opening through a unique regulatory helix (R-helix) release mechanism, while the alternatively spliced C-terminal 42 residues allosterically tune NBD2 nucleotide sensing and drug selectivity [PMID:18311911, PMID:9692785, PMID:38227376]. K-channel opener drugs bind a transmembrane pocket between TMD1 and TMD2 to stabilize the NBD-dimerized occluded activating state, and SUR2 also directs KATP channel trafficking between endosomal and sarcolemmal compartments and participates in neonatal cardiac metabolic maturation from glycolysis to fatty acid oxidation [PMID:35562524, PMID:20971764, PMID:24648545]. Loss-of-function mutations cause AIMS (intellectual disability, myopathy, cardiac dysfunction), gain-of-function mutations cause Cantú syndrome and cardiac arrhythmias including Brugada and early repolarization syndromes, and vascular SUR2 loss produces coronary vasospasm and hypertension [PMID:31575858, PMID:22610116, PMID:24439875, PMID:12122112].\",\n  \"teleology\": [\n    {\n      \"year\": 1996,\n      \"claim\": \"Identification of ABCC9 as encoding two alternatively spliced sulfonylurea receptor isoforms (SUR2A and SUR2B) that partner with Kir6.2 to form tissue-specific KATP channels established the molecular identity of cardiac, skeletal, and vascular smooth muscle KATP regulatory subunits.\",\n      \"evidence\": \"cDNA cloning, Northern blotting, RT-PCR, in situ hybridization, and FISH chromosomal localization\",\n      \"pmids\": [\"8826984\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Stoichiometry of SUR2/Kir6.x assembly not yet defined\", \"Structural basis of SUR2-Kir6.x coupling unknown\"]\n    },\n    {\n      \"year\": 1998,\n      \"claim\": \"Demonstrating that the 42 C-terminal residues distinguishing SUR2A from SUR2B determine subtype-selective pharmacological activation (>100-fold difference in nicorandil EC50) established the molecular basis for isoform-specific drug selectivity.\",\n      \"evidence\": \"Heterologous expression in HEK293T cells with patch-clamp electrophysiology across SUR2 subtypes\",\n      \"pmids\": [\"9692785\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How C-terminal residues structurally couple to the drug-binding site was unknown\", \"Whether this selectivity extends to all K-channel openers was untested\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Knockout mouse studies revealed that SUR2-containing KATP channels are essential regulators of vascular tone, insulin-stimulated glucose uptake, and survival: Sur2-null mice exhibit coronary vasospasm, hypertension, sudden death, and enhanced muscle glucose uptake, defining the in vivo physiological roles of these channels.\",\n      \"evidence\": \"Sur2 knockout mice with hemodynamic monitoring, coronary angiography, nifedipine rescue, hyperinsulinemic clamp, and isolated muscle glucose transport assays\",\n      \"pmids\": [\"12122112\", \"11562480\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Relative contributions of SUR2A vs SUR2B to each phenotype not dissected\", \"Compensatory mechanisms in global knockout not excluded\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Chimeric SUR2A/SUR2B analysis showed that the C-terminal 42 residues interact intramolecularly with Arg1344 at the Walker-A loop of NBD2, providing the first structural model for how isoform-specific C-termini differentially regulate ADP-induced channel activation.\",\n      \"evidence\": \"Chimeric SUR2A/SUR2B constructs with Kir6.2, patch-clamp electrophysiology, homology modeling\",\n      \"pmids\": [\"11909819\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Based on homology modeling rather than direct structural data\", \"Interaction not confirmed by direct binding assays with isolated domains\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Discovery that ABCC9 mutations in dilated cardiomyopathy patients alter the intrinsic ATPase cycle of SUR2A established the first link between aberrant SUR2 catalytic activity and human cardiac disease, demonstrating that SUR2 functions as a metabolic signal decoder.\",\n      \"evidence\": \"Genomic DNA scanning of cardiomyopathy patients, functional expression of mutant SUR2A, inside-out patch-clamp, ATPase activity assays\",\n      \"pmids\": [\"15034580\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Exact structural consequences of mutations on NBD conformation unknown\", \"Whether these mutations also affect trafficking was not tested\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Reconstitution of purified NBD1 and NBD2 domains demonstrated that SUR2A possesses intrinsically asymmetric NBDs whose heterodimeric assembly is required for optimal ATPase catalytic activity, revealing the enzymatic architecture underlying metabolic sensing.\",\n      \"evidence\": \"Purified recombinant NBD1/NBD2, ATPase assays, dynamic light scattering, circular dichroism, AFM, TEM, site-directed mutagenesis of catalytic base D834E\",\n      \"pmids\": [\"18311911\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Full-length SUR2 catalytic cycle not reconstituted\", \"Coupling of NBD ATPase to channel gating not demonstrated biochemically\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"SUR2 was shown to direct KATP channels to intracellular endosomal/lysosomal compartments, with ischemia shifting channel distribution to the sarcolemma; separately, SUR2-null mitochondria showed altered membrane potential, Ca2+ tolerance, and ROS generation, expanding SUR2 function beyond sarcolemmal gating to subcellular trafficking and mitochondrial physiology.\",\n      \"evidence\": \"Immunofluorescence, surface HA-tag labeling, subcellular fractionation of rat hearts, fluorescence-based mitochondrial assays in SUR2-mutant mice\",\n      \"pmids\": [\"20971764\", \"20935152\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular mechanism of ischemia-induced trafficking not defined\", \"Whether SUR2 is physically present in mitochondrial membranes vs. indirectly affecting mitochondria was debated\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Identification of dominant ABCC9 gain-of-function mutations as the cause of Cantú syndrome, with mutations clustering in transmembrane domains and reducing ATP-mediated inhibition of KATP channels, established a new Mendelian channelopathy paradigm for SUR2.\",\n      \"evidence\": \"Exome sequencing of multiple affected families, Sanger validation, electrophysiological measurements of mutant channel ATP sensitivity\",\n      \"pmids\": [\"22610116\", \"22608503\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How different Cantú mutations produce common phenotype despite distinct gating effects unknown\", \"Tissue-specific pathophysiology (cardiac vs. vascular vs. skeletal) not dissected\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Abcc9 exon 5 knockout mice revealed that SUR2 is required for the neonatal heart's metabolic transition from glycolysis to fatty acid oxidation, with loss causing mitochondrial immaturity and neonatal cardiomyopathy, establishing a developmental metabolic role for KATP channels.\",\n      \"evidence\": \"Exon 5 knockout mice, fatty acid oxidation assays, oxygen consumption measurements, electron microscopy of cardiac mitochondria\",\n      \"pmids\": [\"24648545\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether sarcolemmal or mitochondrial KATP (or both) drive metabolic maturation not resolved\", \"Upstream transcriptional regulators of neonatal ABCC9 expression unknown\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Detailed electrophysiological dissection of multiple Cantú syndrome mutations revealed at least two distinct gain-of-function mechanisms: enhanced MgADP activation versus reduced ATP/glibenclamide sensitivity, showing that different mutations converge on channel overactivity through separate gating pathways.\",\n      \"evidence\": \"86Rb efflux assays and inside-out patch-clamp of engineered mutant SUR2A/Kir6.2 channels\",\n      \"pmids\": [\"26621776\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether mixed-mechanism mutations produce different disease severity not tested\", \"Structural basis for mechanistic divergence unknown at the time\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Discovery that homozygous ABCC9 loss-of-function causes AIMS (intellectual disability, myopathy, cardiac dysfunction) in humans, confirmed across mice and zebrafish, completed the allelic series from gain-of-function (Cantú) to loss-of-function and demonstrated SUR2 is essential for muscle and brain function.\",\n      \"evidence\": \"Patient exome sequencing, recombinant channel electrophysiology showing non-functional channels, SUR2 knockout mouse and zebrafish phenotyping\",\n      \"pmids\": [\"31575858\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"CNS pathophysiology mechanism not defined\", \"Whether residual SUR2 splice variants modulate AIMS severity unknown\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Cantú syndrome knockin mouse models revealed that the R1154Q mutation causes near-complete SUR2 protein loss through aberrant mRNA splicing rather than altered gating, and that SUR2[A478V] gain-of-function in skeletal muscle causes atrophy through upregulation of ubiquitin ligases, connecting KATP overactivity to muscle wasting pathways.\",\n      \"evidence\": \"CRISPR knockin mice, cDNA sequencing, recombinant channel expression, hiPSC-derived cardiomyocytes, skeletal muscle patch-clamp, histopathology, and qPCR of atrophy markers\",\n      \"pmids\": [\"33529173\", \"34359961\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Why R1154Q missense causes mis-splicing at the pre-mRNA level is mechanistically unexplained\", \"Downstream signaling from KATP overactivity to atrogin-1/MuRF1 induction not mapped\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Cryo-EM structures of SUR2A and SUR2B with KATP openers and Mg-nucleotides identified a common drug-binding pocket between TMD1 and TMD2 and showed that openers synergize with Mg-nucleotides to stabilize the NBD-dimerized occluded activating conformation, providing the first atomic-level mechanism of KATP opener action on SUR2.\",\n      \"evidence\": \"Cryo-EM structure determination of SUR2A and SUR2B with bound P1075 or levcromakalim\",\n      \"pmids\": [\"35562524\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Transition-state intermediates between inward-facing and occluded conformations not captured\", \"Structures of disease-mutant SUR2 not yet determined\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"KCNJ8/ABCC9-containing KATP channels were shown to cell-autonomously regulate brain vascular smooth muscle cell differentiation through modulation of Ca2+ oscillations via voltage-dependent calcium channels, extending SUR2 function to developmental vascular biology.\",\n      \"evidence\": \"Kcnj8 KO mice, zebrafish models, chemical KATP modulation, live Ca2+ imaging, VSMC differentiation assays\",\n      \"pmids\": [\"35588738\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Transcriptional targets downstream of Ca2+ oscillation changes not identified\", \"Relative contribution of SUR2 vs. Kir6.1 to differentiation signal not separated\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Synthesis of structural data revealed a unique SUR2-specific regulatory helix (R-helix) absent in SUR1 that mediates Mg-ADP-induced channel activation, and confirmed that the C-terminal 42 residues allosterically regulate Mg-nucleotide binding kinetics on NBD2, unifying decades of pharmacological and mutagenesis data into a coherent conformational gating model.\",\n      \"evidence\": \"Review and synthesis of cryo-EM structural studies with functional validation\",\n      \"pmids\": [\"38227376\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"R-helix deletion/mutation experiments in full-length SUR2 not reported\", \"Dynamic conformational pathway from R-helix release to pore opening not resolved\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"The H60Y Cantú syndrome mutation was shown to cause gain-of-function selectively in Kir6.1-SUR2B but not Kir6.2-SUR2B channels, with valine 334 in the Kir6.1 C-terminus identified as the determinant, establishing that ABCC9 disease mutations can exploit pore-subunit isoform differences to produce tissue-selective pathophysiology.\",\n      \"evidence\": \"Membrane potential assays with chimeric Kir6.1/Kir6.2-SUR2 channels, site-directed mutagenesis\",\n      \"pmids\": [\"41448431\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"In vivo tissue-selective phenotype of H60Y not yet characterized\", \"Structural basis of Val334-mediated isoform selectivity not determined\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Key unresolved questions include: the identity and physiological role of a bona fide mitochondrial KATP channel containing SUR2 splice variants; the structural basis of disease-mutant SUR2 conformations; the signaling pathways linking KATP overactivity to skeletal muscle atrophy; and the mechanism by which SUR2 contributes to brain function as revealed by AIMS intellectual disability.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"Mitochondrial KATP molecular composition remains unresolved\", \"No structural data for disease-mutant SUR2\", \"CNS mechanism of AIMS intellectual disability undefined\", \"Signaling cascade from KATP to atrogin-1/MuRF1 not mapped\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140657\", \"supporting_discovery_ids\": [5, 7, 14, 18]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [0, 1, 4, 11, 17, 18, 24]},\n      {\"term_id\": \"GO:0005215\", \"supporting_discovery_ids\": [0, 8, 11]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [0, 8, 24]},\n      {\"term_id\": \"GO:0005768\", \"supporting_discovery_ids\": [8]},\n      {\"term_id\": \"GO:0005739\", \"supporting_discovery_ids\": [9, 16]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-382551\", \"supporting_discovery_ids\": [0, 1, 11, 24]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [2, 3, 25]},\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [5, 11, 17, 20]},\n      {\"term_id\": \"R-HSA-1430728\", \"supporting_discovery_ids\": [2, 16]}\n    ],\n    \"complexes\": [\n      \"KATP channel (SUR2A/Kir6.2)\",\n      \"KATP channel (SUR2B/Kir6.2)\",\n      \"KATP channel (SUR2B/Kir6.1)\"\n    ],\n    \"partners\": [\n      \"KCNJ11\",\n      \"KCNJ8\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}